News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • AtriCure's AtriClip platform could gain widespread adoption if hospitals adopt a new left atrial appendage management quality metric.
  • AtriCure shows improving margins and healthy free cash flow.
  • Analyst recommends a long trade in AtriCure with entry $58.54, stop $50.00, and target $75.00.
  • Bitcoin traded below $76,000, reflecting downward pressure in the crypto market.
  • Binance will close certain European customer accounts by Dec 31 after the EU Markets in Crypto-Assets transition ended.
  • A payments provider disclosed unauthorized access to consumer data, increasing security concerns for crypto users.
  • Lenovo is positioned to benefit from AI hardware demand, with dividend support and recent analyst upgrades.

Latest Articles

Genius Group to host Genius Future Summit on November 5-6, 2026.

Genius Group to host Genius Future Summit on November 5-6, 2026.

Genius Group Limited (NYSE American: GNS) is hosting its second annual Genius Future Summit on November 5-6, 2026, at Genius City in Bali. The event will showcase leading futurists like Dr. Michio Kaku and Peter Diamandis, discuss key future trends in AI, blockchain, and community, and launch new projects including the Genius Awards and Genius City…

Lianhe Sowell International Group Ltd. Signs Strategic Cooperation Agreement with Subsidiary of Chery Group Holding Company to Advance Intelligent Equipment in China’s Automotive Aftermarket

Lianhe Sowell International Group Ltd. Signs Strategic Cooperation Agreement with Subsidiary of Chery Group Holding Company to Advance Intelligent Equipment in China’s Automotive Aftermarket

Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision and automation solutions, has signed a strategic cooperation agreement with Kumquat Technology Co., a Chery Group subsidiary operating 1,000 4S stores across China. This partnership aims to promote intelligent equipment solutions for 24 automotive aftermar…

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

Lantheus Holdings, Inc. announced that the FDA has granted final approval for BRAVNETSA™ (lutetium Lu 177 dotatate), establishing it as the only radiopharmaceutical deemed bioequivalent and therapeutically equivalent to LUTATHERA® for treating somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Approval via the A…

Host Digital Debuts on NYSE American as HOST and Exercises its Right to Acquire a Second Site from its Sponsor for its AI Data Center Platform

Host Digital Debuts on NYSE American as HOST and Exercises its Right to Acquire a Second Site from its Sponsor for its AI Data Center Platform

Host Digital Inc., a U.S.-based digital infrastructure company specializing in AI and high-performance computing data centers, has begun trading on the NYSE American under ticker HOST. The company completed a merger to acquire its initial Site I data center and signed an agreement granting preferential rights to acquire additional sites from its Sp…

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Filana Therapeutics announced the FDA has lifted the clinical hold on simufilam, allowing the company to proceed with a Phase 2a study targeting Tuberous Sclerosis Complex-related epilepsy. Patient screening is expected to begin in early 2027. The 16-week trial will assess safety, tolerability, and efficacy in seizure reduction in 40 patients, supp…

newcleo Begins Trading on Nasdaq Under Symbol "NWCL"

newcleo Begins Trading on Nasdaq Under Symbol "NWCL"

newcleo plc, a pioneer in advanced modular reactor technology and nuclear fuel manufacturing, has started trading on the Nasdaq Global Select Market under the ticker symbol NWCL. The listing supports the company’s growth plans, including completing a demonstrator reactor in Italy, advancing regulatory approvals in the U.S. and Europe, and expanding…

TTEC Launches New Automotive Customer Experience Program in Cairo

TTEC Launches New Automotive Customer Experience Program in Cairo

TTEC Holdings, Inc. has launched a new customer experience operation in Cairo to support Volkswagen Group UK's customer care across digital and voice channels. This expansion leverages TTEC's multilingual workforce, AI-enabled CX technologies, and automotive expertise, enhancing service quality as part of a seven-year strategic collaboration with V…

Comscore's Latest AI Intelligence Report Shows Competition Intensifying as Claude and Gemini Gain Ground on ChatGPT

Comscore's Latest AI Intelligence Report Shows Competition Intensifying as Claude and Gemini Gain Ground on ChatGPT

Comscore's latest report highlights a diversification in AI assistant usage among consumers. While ChatGPT remains the leader, its market share has decreased from 70% to 50% between January and June 2026, as competitors Claude and Google's Gemini increase their shares significantly. AI assistant adoption on mobile devices is accelerating, and AI is…

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

PDS Biotechnology Corporation announced the publication of Phase 2 clinical trial results in JAMA Oncology demonstrating that PDS0101, an HPV16-targeted immunotherapy combined with pembrolizumab, achieved a median overall survival of 39.3 months in immune checkpoint inhibitor-naïve patients with recurrent/metastatic HPV16-positive head and neck can…

Roundtable Files 8-K: Projects $90-$100 Million in 2027 Revenue and Annualized Adjusted EBITDA-Positive Operations

Roundtable Files 8-K: Projects $90-$100 Million in 2027 Revenue and Annualized Adjusted EBITDA-Positive Operations

Roundtable (NASDAQ: RTB), an AI/DeFi-powered Enterprise Media Operating System, announced in a Form 8-K filing its 2027 forecast projecting $102 million in revenue and achieving annualized Adjusted EBITDA-positive operations. The forecast incorporates the Paradium.AI partnership, expected to drive significant operating leverage due to fixed costs a…

TSX Futures Tick Up as Diplomacy Hopes and Xi-Trump Meeting Loom

TSX Futures Tick Up as Diplomacy Hopes and Xi-Trump Meeting Loom

Futures tied to Canada’s primary stock index inched higher as investors weighed diplomatic signals that could ease Middle East oil risks and awaited a high-profile meeting between U.S. President Donald Trump and Chinese President Xi Jinping later in the week. Momentum in AI-linked technology stocks underpinned recent gains on Wall Street, while ene…

Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives

Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives

Cerenome, Inc. announced that its subsidiary CNSide Diagnostics has signed an in-network agreement with Blue Cross Blue Shield of Michigan, expanding CNSide® CSF Tumor Cell Enumeration assay coverage to approximately 158 million commercial and Medicare Advantage covered lives. This agreement significantly enhances patient access and supports the co…

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

Beta Bionics announced a partnership with Senseonics to integrate its iLet Bionic Pancreas and mint automated insulin delivery systems with the Eversense 365 continuous glucose monitoring system. The combined system is expected to launch commercially in Q4 2026, offering users broader device choice and improved diabetes management through advanced …

FTI Consulting Appoints Eileen Fargis as Senior Managing Director to Enhance Power, Renewables and Energy Transition Advisory Capabilities

FTI Consulting Appoints Eileen Fargis as Senior Managing Director to Enhance Power, Renewables and Energy Transition Advisory Capabilities

FTI Consulting has appointed Eileen Fargis as Senior Managing Director in its global Power, Renewables & Energy Transition practice. With extensive experience in the energy sector, Ms. Fargis will advise clients on strategic, financial, and operational challenges amid growing electricity demand, regulatory changes, and capital constraints. Her appo…